The National Institute on Drug Abuse (NIDA) seeks to accelerate the development of medication for the treatment of Substance Use Disorders (SUDs) by encouraging research applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval.
- Letter of Intent Due Dates: 30 days before the application due date
- Application Due Date(s): Applications will be accepted on a rolling basis, beginning on September 3, 2022.
PAR-22-202 Expiration Date September 02, 2025